🔖
Cite This Article
SİVRİKOZ, İ. A., GÜLBAŞ, Z. (2022). A rare presentation of multiple myeloma: Tc-99m MIBI SPECT imaging of orbital involvement. Turkish Journal of Hematology, Cilt: 25 - Sayı: 4, 212–213. https://ajindex.com/articles/607175
Journals / Turkish Journal of Hematology / 2008 / Cilt: 25 - Sayı: 4
A rare presentation of multiple myeloma: Tc-99m MIBI SPECT imaging of orbital involvement
- Pages
- 212–213
- Publication Date
- 2022-11-04
- DOI
- —
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗References (7)
- Fung S, Selva D, Leibovitch I, Hsuan J, Crompton J. Ophthalmic manifestations of multiple myeloma. Ophthalmologica. 2005;219(1):43-8
- Ajithkumar TV, Sivasankar C, Ramachandran K. Orbital multiple myeloma: case report and review of computed tomography features. Australas Radiol. 2002;46(1):119-20
- D'Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Guidelines for the use of imaging in the management of myeloma. Br J Haematol. 2007;137(1):49 63
- Mele A, Offidani M, Visani G et al. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans. Br J Haematol. 2007;136(5):729-35
- Villa G, Balleari E, Carletto M et al.Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience. J Exp Clin Cancer Res. 2005;24(3):355-61
- Catalano L, Andretta C, Pace L et al. Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma. Hematology. 2005;10(4):335-8
- Bacovsky J, Scudla V, Myslivecek M, Nekula J, Vytrasová M. Scintigraphy using (99m)Tc-MIBI (sestamibi), a sensitive parameter of activity of multiple myeloma. Neoplasma. 2005;52(4):302-6.